On-Body Drug Delivery Devices Market Report: Trends, Forecast and Competitive Analysis to 2030

On-Body Drug Delivery Devices Trends and Forecast

The future of the global on-body drug delivery devices market looks promising with opportunities in the cancer, diabetes, and auto-immune disease markets. The global on-body drug delivery devices market is expected to grow with a CAGR of 4.6% from 2024 to 2030. The major drivers for this market are growing incidence of chronic diseases and emergence of new advanced technologies.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

On-Body Drug Delivery Devices by Segment

The study includes a forecast for the global on-body drug delivery devices by device, drug type, application, and region.

On-Body Drug Delivery Devices Market by Device [Shipment Analysis by Value from 2018 to 2030]:

• Wearable Injector
• Patch Pump
• Others

On-Body Drug Delivery Devices Market by Drug Type [Shipment Analysis by Value from 2018 to 2030]:

• Conventional Drugs
• Biologic Products
• Biosimilar Drugs
• Others

On-Body Drug Delivery Devices Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Cancer
• Diabetes
• Auto-Immune Disease
• Others

On-Body Drug Delivery Devices Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of On-Body Drug Delivery Devices Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies on-body drug delivery devices companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the on-body drug delivery devices companies profiled in this report include-

• Enable Injections
• Novo Engineering
• Elcam Medical
• Battelle
• Gerresheimer Ag

On-Body Drug Delivery Devices Market Insights

Lucintel forecasts that wearable injector will remain larger segment over the forecast period due to ease of use.

Within this market, diabetes will remain the largest segment due to high prevalence of diabetes globally and rising need for consistent insulin delivery.

North America will remain the largest region over the forecast period due to high prevalence of chronic diseases like diabetes and cancer.

Features of the Global On-Body Drug Delivery Devices Market

Market Size Estimates: On-body drug delivery devices market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: On-body drug delivery devices market size by device, drug type, application, and region in terms of value ($B).

Regional Analysis: On-body drug delivery devices market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different device, drug types, applications, and regions for the on-body drug delivery devices market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the on-body drug delivery devices market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for on-body drug delivery devices market?

Answer: The global on-body drug delivery devices market is expected to grow with a CAGR of 4.6% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the on-body drug delivery devices market?

Answer: The major drivers for this market are growing incidence of chronic diseases and emergence of new advanced technologies.

Q3. What are the major segments for on-body drug delivery devices market?

Answer: The future of the on-body drug delivery devices market looks promising with opportunities in the cancer, diabetes, and auto-immune disease markets.

Q4. Who are the key on-body drug delivery devices market companies?

Answer: Some of the key on-body drug delivery devices companies are as follows:

• Enable Injections
• Novo Engineering
• Elcam Medical
• Battelle
• Gerresheimer Ag

Q5. Which on-body drug delivery devices market segment will be the largest in future?

Answer: Lucintel forecasts that wearable injector will remain larger segment over the forecast period due to ease of use.

Q6. In on-body drug delivery devices market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to high prevalence of chronic diseases like diabetes and cancer.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the on-body drug delivery devices market by device (wearable injector, patch pump, and others), drug type (conventional drugs, biologic products, biosimilar drugs, and others), application (cancer, diabetes, auto-immune disease, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?